Skip Navigation


NDT Advance Access originally published online on January 31, 2006
Nephrology Dialysis Transplantation 2006 21(6):1564-1569; doi:10.1093/ndt/gfk090
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/6/1564    most recent
gfk090v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Liamis, G.
Right arrow Articles by Elisaf, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liamis, G.
Right arrow Articles by Elisaf, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org


Original Articles: Clinical Nephrology

Therapeutic approach in patients with dysnatraemias

George Liamis, Michalis Kalogirou, Vasilios Saugos and Moses Elisaf

Department of Internal Medicine, Medical School, University of Ioannina, 45110 Ioannina, Greece

Correspondence and offprint requests to: Moses Elisaf, MD, FRSH, FASA, Professor of Medicine, Department of Internal Medicine, University of Ioannina, 45110 Ioannina. Email: egepi{at}cc.uoi.gr

Background. Rapid correction of dysnatraemias is frequently associated with increased morbidity and mortality. Therefore, it is important to estimate the proper volume and type of infusate required to change the serum sodium concentration predictably. The aim of this study is to evaluate the utility or/and the accuracy of the Adrogue–Madias formula in managing patients with hyponatraemia and hypernatraemia.

Methods. Among the 317 patients who either on admission to our internal medicine clinic or during their hospitalization were found to have hyponatraemia or hypernatraemia, we studied 189 patients (59.6%) in whom the administration of intravenous solutions was required for the correction of dysnatraemias.

Results. Twelve hours after starting the administration of intravenous solutions the anticipated as well as the achieved serum sodium concentration were as follows: in volume depleted patients 130.2±4.1 vs 131.3±5.2 meq/l (n = 45; P = NS), in syndrome of inappropriate antidiuretic hormone secretion (SIADH) patients 127.4±5.7 vs 128.9±5.9 meq/l (n = 10; P = NS), in patients with diuretic-induced hyponatraemia 123.8±6 vs 125.5±5.6 meq/l (n = 29; P = NS), in patients with primary polydipsia 122.5±0.7 vs 129±1.4 meq/l (n = 2; P = 0.02), while in patients with hypernatraemia 153.6±7.5 vs 156.5±8.9 meq/l (n = 92; P = 0.021). Furthermore, 24 h from the initiation of the therapeutic intervention the expected and the achieved serum sodium concentrations were 130±4 vs 135.6±3.3 meq/l (n = 15; P = 0.002) in patients with volume depletion, 128.1±4.8 vs 130±4.5 meq/l (n = 15; P = NS) in patients with diuretic-induced hyponatraemia and 151.5±6.4 vs 153.3±8.3 meq/l (n = 67; P = NS) in patients with hypernatraemia.

Conclusions. The formula that has been proposed by Adrogue and Madias predicted with relative accuracy the changes in serum sodium concentration in almost all patients. Thus, it should be considered as a very useful tool for the management of dysnatraemias. However, special attention should be paid when this equation is used in patients with hyponatraemia due to extracellular volume depletion after euvolaemia's restoration and primary polydipsia in order to avoid rapid correction of hyponatraemia.

Keywords: adrogue–madias formula; hypernatraemia; hyponatraemia


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
G. Lindner, C. Schwarz, N. Kneidinger, L. Kramer, R. Oberbauer, and W. Druml
Can we really predict the change in serum sodium levels? An analysis of currently proposed formulae in hypernatraemic patients
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3501 - 3508.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Liamis, V. Tsimihodimos, M. Doumas, A. Spyrou, E. Bairaktari, and M. Elisaf
Clinical and laboratory characteristics of hypernatraemia in an internal medicine clinic
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 136 - 143.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
H. K. Mohmand, D. Issa, Z. Ahmad, J. D. Cappuccio, R. W. Kouides, and R. H. Sterns
Hypertonic Saline for Hyponatremia: Risk of Inadvertent Overcorrection
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1110 - 1117.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
T. Berl
The Adrogue-Madias Formula Revisited
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1098 - 1099.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
M Biswas and J S Davies
Hyponatraemia in clinical practice
Postgrad. Med. J., June 1, 2007; 83(980): 373 - 378.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. H. Ellison and T. Berl
The Syndrome of Inappropriate Antidiuresis
N. Engl. J. Med., May 17, 2007; 356(20): 2064 - 2072.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.